|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT00736554 |
|
Date of registration:
|
14/08/2008 |
|
Primary sponsor: |
|
|
Public title:
|
What is the Prevalence of Methicillin-Resistant Staphylococcus Aureus in Skin and Soft Tissue Infections Presenting to the Emergency Departments of a Canadian Academic Health Care Center?
CA-MRSA |
|
Scientific title:
|
Prevalence of MRSA in Skin and Soft Tissue Infections in Two Ontario Emergency Departments. |
|
Date of first enrolment:
|
July 2008 |
|
Target sample size:
|
152 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT00736554 |
|
Study type:
|
Observational |
|
Study design:
|
Observational Model: Cohort, Time Perspective: Prospective
|
|
|
Countries of recruitment
|
|
Canada
| | | | | | | |
|
Contacts
|
|
Name:
|
Christopher MB Fernandes, FRCP, FACEP, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
University of Western Ontario, Canada |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- All adult patients (> 17 years) whose chief complaint is consistent with skin or soft
tissue infection (cellulitis, necrotizing soft tissue infection, wound infection,
ulcer, septic bursitis, abscess including furuncle/carbuncle/superficial skin
abscess, paronychia, hordeolum, pilonidal abscess, acute lymphadenitis, pilonidal
cyst without abscess, and impetigo).
Exclusion Criteria:
- Patients will be excluded if they refuse to participate or written, informed consent
is not obtained.
- Additionally, patients with Bartholin cysts, odontogenic infections and perianal
abscesses will be excluded.
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Bacterial Infections
|
|
Gram-Positive Bacterial Infections
|
|
Staphylococcal Infections
|
|
Secondary ID(s)
|
|
13871E
|
|
R-08-173
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|